TW200637560A - Ampa antagonists for the treatment of dizziness, including vertigo and meniere's disorder - Google Patents

Ampa antagonists for the treatment of dizziness, including vertigo and meniere's disorder

Info

Publication number
TW200637560A
TW200637560A TW095101439A TW95101439A TW200637560A TW 200637560 A TW200637560 A TW 200637560A TW 095101439 A TW095101439 A TW 095101439A TW 95101439 A TW95101439 A TW 95101439A TW 200637560 A TW200637560 A TW 200637560A
Authority
TW
Taiwan
Prior art keywords
dizziness
disorder
treatment
meniere
including vertigo
Prior art date
Application number
TW095101439A
Other languages
Chinese (zh)
Inventor
Lechoslaw A Turski
Van Bernard J Vliet
Rene Remie
Van Der Johannes A M Heijden
Martinus Th M Tulp
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Publication of TW200637560A publication Critical patent/TW200637560A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

Abstract

The invention relates to the use of 8,9-dimethyl-5-phenyl-11H-1,3-dioxolo[4,5-h]-imidazo[1,2-c][2,3]benzodiazepine: tautomers and N-oxides thereof, as well as pharmacologically acceptable salts, hydrates and solvates of this compound and its tautomers and N-oxides, for the preparation of a pharmaceutical composition for the treatment, amelioration or prevention of dizziness, including vertigo and Menire's disorder.
TW095101439A 2005-01-14 2006-01-13 Ampa antagonists for the treatment of dizziness, including vertigo and meniere's disorder TW200637560A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05100205 2005-01-14

Publications (1)

Publication Number Publication Date
TW200637560A true TW200637560A (en) 2006-11-01

Family

ID=34938515

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095101439A TW200637560A (en) 2005-01-14 2006-01-13 Ampa antagonists for the treatment of dizziness, including vertigo and meniere's disorder

Country Status (2)

Country Link
AR (1) AR052872A1 (en)
TW (1) TW200637560A (en)

Also Published As

Publication number Publication date
AR052872A1 (en) 2007-04-11

Similar Documents

Publication Publication Date Title
SG146657A1 (en) Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
DE602006005477D1 (en) Imidazopyridinverbindungen
WO2001066534A3 (en) Cyclic and bicyclic diamino histamine-3 receptor antagonists
WO2006126082A3 (en) Pyridine [3,4-b] pyrazinones as pde-5 inhibitors
MX2008001606A (en) Substituted piperazines as metabotropic glutamate receptor antagonists.
TW200510297A (en) Substituted n-aryl heterocycles, process for their preparation and their use as medicaments
AU2003242544A1 (en) New indolylpiperidine derivatives as potent antihistaminic and antiallergic agents
UA83091C2 (en) Pyrido[2,3-d]pyrimidine-2,4-diamines as pde 2 inhibitors
MX2007006387A (en) 3-substituted pyridine derivatives as h3 antagonists.
HK1105979A1 (en) Pyrrolo [3,2-c] pyridine derivatives and processes for the preparation
WO2006011050A3 (en) Pyridine derivatives
PL373414A1 (en) 8-methoxy-(1,2,4)triazolo(1,5-a)pyridine derivatives and their use as adenosine receptor ligands
IL174678A0 (en) Arylindenophyridines and arylindenophyrimidines and their use as adenosine a2a receptor antagonist
IL191751A0 (en) Pyrrolo[2,3-c]pyridine derivatives
MY150747A (en) Pyrido[2,3-d] pyrimidin-7-one compounds as inhibitors of pi3k-alpha for the treatment of cancer
JO2550B1 (en) Pyrido [2,3-d] pyrimidine derivatives, preperation thereof, Therapeutic use thereof
WO2004094431A3 (en) 2-alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine a2a receptor antagonists
PL1899350T3 (en) Pyrazolo [3 , 4-d]azepine derivatives as histamine h3 antagonists
MXPA03005601A (en) Novel compounds and compositions as cathepsin inhibitors.
MX2007007027A (en) Piperazinyl pyridine derivatives as anti-obesity agents.
MX2008001607A (en) Bicyclic piperazines as metabotropic glutamate receptor antagonists.
UA93522C2 (en) 2-amino-7,8-dihydro-6h-pyrido[4,3-d] pyrimidin-5-ones
AU2003226765A8 (en) Azaindolylpiperidine derivatives as antihistaminic and antiallergic agents
TW200637560A (en) Ampa antagonists for the treatment of dizziness, including vertigo and meniere's disorder
MY148488A (en) Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists